دورية أكاديمية

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study

التفاصيل البيبلوغرافية
العنوان: Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study
المؤلفون: Rhodes, CJ, Wharton, J, Ghataorhe, P, Watson, G, Girerd, B, Howard, LS, Gibbs, JSR, Condliffe, R, Elliot, CA, Kiely, DG, Simonneau, G, Montani, D, Sitbon, O, Gall, H, Schermuly, RT, Ghofrani, HA, Lawrie, A, Humbert, M, Wilkins, MR
المساهمون: Imperial College Healthcare NHS Trust, National Institute for Health Research, British Heart Foundation, Wellcome Trust, Medical Research Council (MRC)
المصدر: 726 ; 717
بيانات النشر: Elsevier
سنة النشر: 2017
المجموعة: Imperial College London: Spiral
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Critical Care Medicine, Respiratory System, General & Internal Medicine, PREDICTING SURVIVAL, EXPRESSION, IDENTIFICATION, BIOMARKERS, DIAGNOSIS, RECEPTOR, ST2, Adult, Aged, Arterial Pressure, Blood Proteins, Cohort Studies, Familial Primary Pulmonary Hypertension, Female, Humans, Hypertension, Male, Middle Aged, Proteome, Risk Assessment, Risk Factors, 1103 Clinical Sciences, 1117 Public Health and Health Services, 1199 Other Medical and Health Sciences
الوصف: BACKGROUND: Idiopathic and heritable pulmonary arterial hypertension form a rare but molecularly heterogeneous disease group. We aimed to measure and validate differences in plasma concentrations of proteins that are associated with survival in patients with idiopathic or heritable pulmonary arterial hypertension to improve risk stratification. METHODS: In this observational cohort study, we enrolled patients with idiopathic or heritable pulmonary arterial hypertension from London (UK; cohorts 1 and 2), Giessen (Germany; cohort 3), and Paris (France; cohort 4). Blood samples were collected at routine clinical appointment visits, clinical data were collected within 30 days of blood sampling, and biochemical data were collected within 7 days of blood sampling. We used an aptamer-based assay of 1129 plasma proteins, and patient clinical details were concealed to the technicians. We identified a panel of prognostic proteins, confirmed with alternative targeted assays, which we evaluated against the established prognostic risk equation for pulmonary arterial hypertension derived from the REVEAL registry. All-cause mortality was the primary endpoint. FINDINGS: 20 proteins differentiated survivors and non-survivors in 143 consecutive patients with idiopathic or heritable pulmonary arterial hypertension with 2 years' follow-up (cohort 1) and in a further 75 patients with 2·5 years' follow-up (cohort 2). Nine proteins were both prognostic independent of plasma NT-proBNP concentrations and confirmed by targeted assays. The functions of these proteins relate to myocardial stress, inflammation, pulmonary vascular cellular dysfunction and structural dysregulation, iron status, and coagulation. A cutoff-based score using the panel of nine proteins provided prognostic information independent of the REVEAL equation, improving the C statistic from area under the curve 0·83 (for REVEAL risk score, 95% CI 0·77-0·89; p<0·0001) to 0·91 (for panel and REVEAL 0·87-0·96; p<0·0001) and improving reclassification indices without ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2213-2600
العلاقة: 10044/1/49893; http://hdl.handle.net/10044/1/49893Test; Lancet Respiratory Medicine; http://hdl.handle.net/10044/1/48077Test; N/A; 84800; FS/15/59/31839; RG68204 13/EE/0203 A092860; RG/10/16/28575; 103378/Z/13/Z; MC_PC_14100
DOI: 10.1016/S2213-2600(17)30161-3
الإتاحة: https://doi.org/10.1016/S2213-2600Test(17)30161-3
http://hdl.handle.net/10044/1/48077Test
حقوق: © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licence (https://creativecommons.org/licenses/by/4.0Test/)
رقم الانضمام: edsbas.F881CB3D
قاعدة البيانات: BASE
الوصف
تدمد:22132600
DOI:10.1016/S2213-2600(17)30161-3